Neoadjuvant human epidermal growth factor receptor-2 targeted therapy in patients with locally advanced breast cancer
{{output}}
Purpose: We analyzed the responses of patients with locally advanced breast cancer to neoadjuvant chemotherapy (NAC) and NAC combined with neoadjuvant human epidermal growth factor receptor-2 (HER2) targeted therapy (NCHTT). ... ...
